{
    "organizations": [],
    "uuid": "aeba5b84100841d3b8ee2c3a995d65a4b69c2d3f",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-median-technologies-fy-net-loss-wi/brief-median-technologies-fy-net-loss-widens-to-17-2-million-euros-idUSFWN1RP0W0",
    "ord_in_thread": 0,
    "title": "BRIEF-Median Technologies FY Net Loss Widens To 17.2 Million Euros",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 12 (Reuters) - Median Technologies SA:\n* FY NET LOSS EUR 17.2 MILLION VERSUS LOSS EUR 9.1 MILLION YEAR AGO\n* FY OPERATING LOSS EUR 17.1 MILLION VERSUS LOSS EUR 9.3 MILLION YEAR AGO\n* IN 2018, CO WILL FOCUS ON DEVELOPING AND FOSTERING PARTNERSHIPS WITH PHARMACEUTICAL CUSTOMERS AND CLINICAL RESEARCH ORGANIZATIONS Source text for Eikon: Further company coverage: (Gdynia Newsroom:)\n ",
    "published": "2018-04-13T00:34:00.000+03:00",
    "crawled": "2018-04-13T17:35:25.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "median",
        "technology",
        "sa",
        "fy",
        "net",
        "loss",
        "eur",
        "million",
        "versus",
        "loss",
        "eur",
        "million",
        "year",
        "ago",
        "fy",
        "operating",
        "loss",
        "eur",
        "million",
        "versus",
        "loss",
        "eur",
        "million",
        "year",
        "ago",
        "co",
        "focus",
        "developing",
        "fostering",
        "partnership",
        "pharmaceutical",
        "customer",
        "clinical",
        "research",
        "organization",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}